Back to Search Start Over

Neoadjuvant Anti-PD-1 Immunotherapy Leads to Survival Benefit in Recurrent Glioblastoma

Authors :
W. Christopher Newman
Nduka Amankulor
Source :
Neurosurgery. 85(2)
Publication Year :
2019

Subjects

Subjects :
Oncology
medicine.medical_specialty
business.industry
medicine.medical_treatment
Recurrent glioblastoma
Anti pd 1
MEDLINE
Immunotherapy
medicine.disease
Survival benefit
Internal medicine
medicine
Surgery
Neurology (clinical)
business
Neoadjuvant therapy
Glioblastoma

Details

ISSN :
15244040
Volume :
85
Issue :
2
Database :
OpenAIRE
Journal :
Neurosurgery
Accession number :
edsair.doi.dedup.....7e40c8956c52a04f31dc9b979fb7506d

Tools

Authors Abstract Subjects Details